CLOVER HEALTH INVEST

CLOV
Delayed Quote. Delayed  - 06/24 04:00:00 pm
13.79USD -0.29%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 673819
EBITDA1 -74,4-229
Operating profit (EBIT)1 -92,7-230
Operating Margin -13,8%-28,0%
Pre-Tax Profit (EBT)1 -91,653,0
Net income1 -136-118
Net margin -20,3%-14,4%
EPS2 -3,18-0,51
Dividend per Share2 --
Announcement Date 03/01/2021-
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 71,5249
Leverage (Debt / EBITDA) 0,96x1,09x
Free Cash Flow1 --202
ROE (Net Profit / Equities) --48,8%
Shareholders' equity1 -242
ROA (Net Profit / Asset) -45,1%-22,7%
Assets1 302519
Book Value Per Share2 -1,71
Cash Flow per Share2 -2,76-0,55
Capex1 0,69-
Capex / Sales 0,10%-
Announcement Date 03/01/2021-
1 USD in Million
2 USD
Financial Ratios
Size 2021e 2022e
Capitalization 5 644 M $ -
Entreprise Value (EV) 5 395 M $ 5 181 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) -27,4x -75,1x
Capitalization / Revenue 6,89x 5,30x
EV / Revenue 6,59x 5,07x
EV / EBITDA -23,6x -64,9x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 8,09x 8,55x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -28,0% -11,7%
Operating Leverage (Delta EBIT / Delta Sales) - 1,53x
Net Margin (Net Profit / Revenue) -14,4% -3,56%
ROA (Net Profit / Asset) -22,7% 3,29%
ROE (Net Profit / Equities) -48,8% -5,37%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   -0 0,19%
Cash Flow / Sales -27,6% -8,08%
Capital Intensity (Assets / Sales) 0,63x -1,08x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend